Ray Dalio Axonics, Inc. Transaction History
Bridgewater Associates, LP
- $19.6 Billion
- Q1 2024
A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Axonics, Inc. stock. As of the latest transaction made, Bridgewater Associates, LP holds 46,499 shares of AXNX stock, worth $3.12 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
46,499
Previous 54,156
14.14%
Holding current value
$3.12 Million
Previous $3.37 Million
4.84%
% of portfolio
0.02%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding AXNX
# of Institutions
240Shares Held
41.8MCall Options Held
213KPut Options Held
362K-
Vanguard Group Inc Valley Forge, PA5.04MShares$338 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.29MShares$288 Million0.01% of portfolio
-
Alpine Associates Management Inc. Englewood Cliffs, NJ1.81MShares$122 Million4.89% of portfolio
-
Fil LTD Hamilton, D01.72MShares$115 Million0.12% of portfolio
-
Mackenzie Financial Corp Toronto Ontario, A61.27MShares$85 Million0.13% of portfolio
About Axonics, Inc.
- Ticker AXNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 49,123,600
- Market Cap $3.3B
- Description
- Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...